Case Report

Published on 23 Jan 2024

Sequential autologous CAR-T and allogeneic CAR-T therapy successfully treats central nervous system involvement relapsed/refractory ALL: a case report and literature review

in Hematologic Malignancies

Yifan Liu
Yanfen Li
Zhangyu Yu
Rongrong Wang
Yu Jing

Frontiers in Oncology

doi 10.3389/fonc.2024.1341682

1,604 views

Review

Published on 23 Jan 2024

Immune checkpoint blockade in hematological malignancies: current state and future potential

in Hematologic Malignancies

Prateek Pophali
Juan Carlos Varela
Jacalyn Rosenblatt

Frontiers in Oncology

doi 10.3389/fonc.2024.1323914

2,451 views
1 citation

Original Research

Published on 23 Jan 2024

Stromal area differences with epithelial-mesenchymal transition gene changes in conjunctival and orbital mucosa-associated lymphoid tissue lymphoma

in Hematologic Malignancies

Mizuki Tagami
Hiroaki Kasashima
Anna Kakehashi
Atsuko Yoshikawa
Mizuho Nishio
Norihiko Misawa
Atsushi Sakai
Hideki Wanibuchi
Masakazu Yashiro
Atsushi Azumi

Frontiers in Oncology

doi 10.3389/fonc.2024.1277749

855 views
1 citation

Case Report

Published on 19 Jan 2024

Brentuximab vedotin as a bridge to combination chemotherapy in gray zone lymphoma with severe liver impairment: a case report

in Hematologic Malignancies

Roshan Asrani
Turgot Bora Cengiz
Bruce E. Petersen
Theodora Anagnostou
Joshua D. Brody

Frontiers in Oncology

doi 10.3389/fonc.2023.1254256

962 views

Original Research

Published on 19 Jan 2024

Non-invasive detection of lymphoma with circulating tumor DNA features and protein tumor markers

in Hematologic Malignancies

Yu Chang
Shiyong Li
Zhiming Li
Xinhua Wang
Fangyuan Chang
Shuaipeng Geng
Dandan Zhu
Guolin Zhong
Wei Wu
Yinyin Chang

Frontiers in Oncology

doi 10.3389/fonc.2024.1341997

1,382 views

Original Research

Published on 17 Jan 2024

On-demand plerixafor added to high-dose cyclophosphamide and pegylated recombinant human granulocyte colony-stimulating factor in the mobilization of patients with multiple myeloma: a treatment with high effectiveness, convenient, and affordable cost

in Hematologic Malignancies

Li-qiong Hou
Jun-Ru Liu
Jing-Li Gu
Mei-Lan Chen
Li-Fen Kuang
Bei-Hui Huang
Wai-yi Zou
Juan Li

Frontiers in Oncology

doi 10.3389/fonc.2023.1306367

1,028 views

Original Research

Published on 15 Jan 2024

Prognostic significance of Wilms’ tumor gene 1 expression in children with B-cell precursor acute lymphoblastic leukemia

in Hematologic Malignancies

Yu-juan Xue
Yu Wang
Le-ping Zhang
Ai-dong Lu
Yue-ping Jia
Ying-xi Zuo
Hui-min Zeng

Frontiers in Oncology

doi 10.3389/fonc.2023.1297870

911 views

Review

Published on 12 Jan 2024

Co-occurrence of JAK2-V617 F mutation and BCR::ABL1 translocation in chronic myeloproliferative neoplasms: a potentially confounding genetic combination

in Hematologic Malignancies

Magda Zanelli
Alessandra Bisagni
Francesca Sanguedolce
Giuseppe Broggi
Valentina Fragliasso
Maurizio Zizzo
Andrea Palicelli
Giovanni Martino
Camilla Cresta
Cecilia Caprera

Frontiers in Oncology

doi 10.3389/fonc.2023.1329298

2,220 views
1 citation

Original Research

Published on 11 Jan 2024

Identification and validation of a prognostic risk-scoring model for AML based on m7G-associated gene clustering

in Hematologic Malignancies

Chiyi Zhang
Ruiting Wen
Guocai Wu
Guangru Li
Xiaoqing Wu
Yunmiao Guo
Zhigang Yang

Frontiers in Oncology

doi 10.3389/fonc.2023.1301236

1,550 views

Case Report

Published on 09 Jan 2024

Ropeginterferon alfa-2b treatment in a young patient with multi-refractory polycythemia vera and double JAK2 gene mutation: a case report

in Hematologic Malignancies

Silvio Ligia
Emilia Scalzulli
Ida Carmosino
Giovanna Palumbo
Maria Chiara Molinari
Rebecca Poggiali
Alessandro Costa
Maria Laura Bisegna
Maurizio Martelli
Massimo Breccia

Frontiers in Oncology

doi 10.3389/fonc.2023.1338417

1,503 views
1 citation

Review

Published on 08 Jan 2024

Extracellular vesicles in the Chronic Myeloid Leukemia scenario: an update about the shuttling of disease markers and therapeutic molecules

in Hematologic Malignancies

Simona Bernardi
Olga Mulas
Silvia Mutti
Alessandro Costa
Domenico Russo
Giorgio La Nasa

Frontiers in Oncology

doi 10.3389/fonc.2023.1239042

1,511 views

Original Research

Published on 05 Jan 2024

Subclassification of B-acute lymphoblastic leukemia according to age, immunophenotype and microenvironment, predicts MRD risk in Mexican children from vulnerable regions

in Hematologic Malignancies

Rubí Romo-Rodríguez
Gabriela Zamora-Herrera
Jebea A. López-Blanco
Lucero López-García
Arely Rosas-Cruz
Laura Alfaro-Hernández
César Omar Trejo-Pichardo
Dulce Rosario Alberto-Aguilar
Diana Casique-Aguirre
Armando Vilchis-Ordoñez

Frontiers in Oncology

doi 10.3389/fonc.2023.1304662

3,921 views

Original Research

Published on 04 Jan 2024

Simulating neuronal development: exploring potential mechanisms for central nervous system metastasis in acute lymphoblastic leukemia

in Hematologic Malignancies

Ziping Li
Zhi Guo
Haitao Xiao
Xuexing Chen
Wei Liu
Hao Zhou

Frontiers in Oncology

doi 10.3389/fonc.2023.1331802

1,138 views

Brief Research Report

Published on 04 Jan 2024

A germline JAK2 exon12 mutation and a late somatic CALR mutation in a patient with essential thrombocythemia

in Hematologic Malignancies

Zhuanghui Hao
Juan Li
Feng Gao
Weixiao Ren
Xiaomei Lu
Jinyi Feng
Chen Zhang
Sicheng Bian
Juan Xie
Ming Luo

Frontiers in Oncology

doi 10.3389/fonc.2023.1265022

1,327 views

Case Report

Published on 03 Jan 2024

Case report: EBV-positive epithelioid follicular dendritic cell sarcoma with CD30 expression: a highly challenging diagnosis

in Hematologic Malignancies

Ying Chen
Xin He
Xingyan Zhu
Yujuan Xu
Deyu Guo

Frontiers in Oncology

doi 10.3389/fonc.2023.1321565

971 views

Review

Published on 20 Dec 2023

Tyrosine Kinase Inhibitors in pediatric chronic myeloid leukemia: a focused review of clinical trials

in Hematologic Malignancies

Fateen Ata
Maria Benkhadra
Rola Ghasoub
Liam J. Fernyhough
Nabil E. Omar
Abdulqadir J. Nashwan
Mahmood B. Aldapt
Kamran Mushtaq
Nancy A. Kassem
Mohamed A. Yassin

Frontiers in Oncology

doi 10.3389/fonc.2023.1285346

1,984 views

Navigation group

Articles

Sequential autologous CAR-T and allogeneic CAR-T therapy successfully treats central nervous system involvement relapsed/refractory ALL: a case report and literature review

Immune checkpoint blockade in hematological malignancies: current state and future potential

Stromal area differences with epithelial-mesenchymal transition gene changes in conjunctival and orbital mucosa-associated lymphoid tissue lymphoma

Brentuximab vedotin as a bridge to combination chemotherapy in gray zone lymphoma with severe liver impairment: a case report

Non-invasive detection of lymphoma with circulating tumor DNA features and protein tumor markers

On-demand plerixafor added to high-dose cyclophosphamide and pegylated recombinant human granulocyte colony-stimulating factor in the mobilization of patients with multiple myeloma: a treatment with high effectiveness, convenient, and affordable cost

Prognostic significance of Wilms’ tumor gene 1 expression in children with B-cell precursor acute lymphoblastic leukemia

Co-occurrence of JAK2-V617 F mutation and BCR::ABL1 translocation in chronic myeloproliferative neoplasms: a potentially confounding genetic combination

Identification and validation of a prognostic risk-scoring model for AML based on m7G-associated gene clustering

Ropeginterferon alfa-2b treatment in a young patient with multi-refractory polycythemia vera and double JAK2 gene mutation: a case report

Extracellular vesicles in the Chronic Myeloid Leukemia scenario: an update about the shuttling of disease markers and therapeutic molecules

Subclassification of B-acute lymphoblastic leukemia according to age, immunophenotype and microenvironment, predicts MRD risk in Mexican children from vulnerable regions

Simulating neuronal development: exploring potential mechanisms for central nervous system metastasis in acute lymphoblastic leukemia

A germline JAK2 exon12 mutation and a late somatic CALR mutation in a patient with essential thrombocythemia

Case report: EBV-positive epithelioid follicular dendritic cell sarcoma with CD30 expression: a highly challenging diagnosis

Tyrosine Kinase Inhibitors in pediatric chronic myeloid leukemia: a focused review of clinical trials